EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Upconversion Nanoparticles with Mesoporous Silica Coatings for Doxorubicin Targeted Delivery to Melanoma Cells

Párástu Oskoei iD, Rúben Afonso, Verónica Bastos iD, João Nogueira iD, Lisa-Marie Keller, Elina Andresen, Maysoon I Saleh, Bastian Rühle iD, Ute Resch-Genger, Ana L Daniel-da-Silva iD, Helena Oliveira iD

Molecules · 2025

DOI: 10.3390/molecules31010074 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2025. Verfasst von Párástu Oskoei und 10 weiteren Autor:innen. Beteiligte Einrichtung: CESAM-Centre for Environmental and Marine Studies, Department of Biology, University of Aveiro, Campus Universitário de Santiago, 3810-193 Aveiro, Po…. Hauptthemen laut MEDLINE: Doxorubicin, Silicon Dioxide, Nanoparticles, Melanoma. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação para a Ciência e Tecnologia, FCT/MCTES (PIDDAC), FEDER and FCT/MCTES.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Melanoma is one of the most aggressive skin cancers and requires innovative therapeutic strategies to overcome the limitations of conventional therapies. In this work, upconversion nanoparticles coated with mesoporous silica and functionalized with folic acid (UCNP@mSiO2-FA) were developed as a targeted nanocarrier system for the delivery of doxorubicin (DOX). The UCNPs were synthesized via thermal decomposition, coated with mesoporous silica shells, and functionalized with folic acid (FA) to enable receptor-mediated targeting. DOX was then loaded into the mesoporous silica coating by adsorption, yielding UCNP@mSiO2-FA-DOX. The different UCNPs were characterized for size, composition, colloidal stability, and loading and release of DOX. This comprehensive physicochemical characterization confirmed a high DOX loading efficiency and a slightly increased drug release under acidic conditions, mimicking the tumour microenvironment. In vitro assays using four melanoma cell lines (A375, B16-F10, MNT-1, and SK-MEL-28) revealed an excellent biocompatibility of UCNP@mSiO2-FA and a significantly higher cytotoxicity of UCNP@mSiO2-FA-DOX compared to unloaded UCNPs, in a dose-dependent manner. Cell cycle analysis demonstrated G2/M phase arrest after treatment with UCNP@mSiO2-FA-DOX, confirming its antiproliferative effect. Overall, UCNP@mSiO2-FA-DOX represents a promising nanoplatform for targeted melanoma therapy, combining active tumour targeting and enhanced anticancer efficacy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DoxorubicinSilicon DioxideNanoparticlesMelanomaDrug Delivery SystemsHumansPorosityCell Line, TumorFolic AcidDrug CarriersDrug LiberationAnimalsMice

Stichwörter der Autor:innen

chemotherapyfolic acidmelanoma cellsmesoporous silica shelltargeted deliveryupconversion nanoparticles

Substanzen

DoxorubicinSilicon DioxideFolic AcidDrug Carriers

Autor:innen und Institutionen

  • CESAM-Centre for Environmental and Marine Studies, Department of Biology, University of Aveiro, Campus Universitário de Santiago, 3810-193 Aveiro, Portugal.
  • CICECO-Aveiro Institute of Materials, Department of Chemistry, University of Aveiro, Campus Universitário de Santiago, 3810-193 Aveiro, Portugal.
  • Federal Institute for Material Research Testing (BAM), Unter den Eichen 87, 12205 Berlin, Germany.

ORCID-Profile: Párástu Oskoei, Verónica Bastos, João Nogueira, Bastian Rühle, Ana L Daniel-da-Silva, Helena Oliveira

Förderung

  • Fundação para a Ciência e Tecnologia
  • FCT/MCTES (PIDDAC)
  • FEDER and FCT/MCTES
  • Federal Institute For Materials Research and Testing

Zitieren

APA

Oskoei, P., Afonso, R., Bastos, V., Nogueira, J., Keller, L. M., Andresen, E., Saleh, M. I., Rühle, B., Resch-Genger, U., Daniel-da-Silva, A. L., & Oliveira, H. (2025). Upconversion Nanoparticles with Mesoporous Silica Coatings for Doxorubicin Targeted Delivery to Melanoma Cells. Molecules. https://doi.org/10.3390/molecules31010074

Vancouver

Oskoei P, Afonso R, Bastos V, Nogueira J, Keller LM, Andresen E, et al. Upconversion Nanoparticles with Mesoporous Silica Coatings for Doxorubicin Targeted Delivery to Melanoma Cells. Molecules. 2025. doi:10.3390/molecules31010074

BibTeX
@article{Oskoei2025,
  author = {Oskoei, Párástu and Afonso, Rúben and Bastos, Verónica and Nogueira, João and Keller, Lisa-Marie and Andresen, Elina and Saleh, Maysoon I and Rühle, Bastian and Resch-Genger, Ute and Daniel-da-Silva, Ana L and Oliveira, Helena},
  title = {Upconversion Nanoparticles with Mesoporous Silica Coatings for Doxorubicin Targeted Delivery to Melanoma Cells},
  journal = {Molecules},
  year = {2025},
  doi = {10.3390/molecules31010074}
}
Kostenlos starten →